NEW_CURA-LEAF_1170x120_OCT

Robert Coopman

Don’t overlook biotherapeutics opportunity

Don’t overlook biotherapeutics opportunity

As a class, biotherapeutic agents are far too significant a chain pharmacy service and business opportunity to ignore. Over recent years biotherapeutic treatments have become significant, both as therapeutic options and as business opportunities. In 2015, six of the top-10-selling medications by sales volume level were biotech agents. Combined sales of the six totaled $56

Where would we be with no generics?

Where would we be with no generics?

The numbers are in for medication spending in the U.S. for the year 2015. And the story headline could read: Thank You, Generic Medication Industry. Another headline for the same story could read: Alarming U.S. Medication Cost Increase of 12% for 2015. Both headlines would be defensibly accurate. The details are in the continuing bifurcation

Small chains show they can compete

Small chains show they can compete

Large chains — Walgreens, CVS/Pharmacy, Rite Aid and Walmart among them — receive a great deal of attention. Similarly, regional chains including Wegmans, H-E-B, Publix and Schnucks are examples of a force in their respective markets. In smaller geographical and local markets, small drug chains, competing with the aforementioned “big boys,” continue to thrive. There